Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Effect of a hydrophilic formulation of topical paromomycin on cutaneous leishmaniasis among patients with contraindications for treatment with pentavalent antimonials].
Santos AM, Noronha EF, Ferreira LA, Carranza-Tamayo CO, Cupolillo E, Romero GA. Santos AM, et al. Among authors: carranza tamayo co. Rev Soc Bras Med Trop. 2008 Sep-Oct;41(5):444-8. doi: 10.1590/s0037-86822008000500002. Rev Soc Bras Med Trop. 2008. PMID: 19009183 Free article. Portuguese.
Autochthonous visceral leishmaniasis in Brasília, Federal District, Brazil.
Carranza-Tamayo CO, Carvalho Mdo S, Bredt A, Bofil MI, Rodrigues RM, Silva AD, Cortez SM, Romero GA. Carranza-Tamayo CO, et al. Rev Soc Bras Med Trop. 2010 Jul-Aug;43(4):396-9. doi: 10.1590/s0037-86822010000400012. Rev Soc Bras Med Trop. 2010. PMID: 20802938 Free article.
Efficacy and safety of amphotericin B deoxycholate versus N-methylglucamine antimoniate in pediatric visceral leishmaniasis: an open-label, randomized, and controlled pilot trial in Brazil.
Borges MM, Pranchevicius MC, Noronha EF, Romero GA, Carranza-Tamayo CO. Borges MM, et al. Among authors: carranza tamayo co. Rev Soc Bras Med Trop. 2017 Jan-Feb;50(1):67-74. doi: 10.1590/0037-8682-0455-2016. Rev Soc Bras Med Trop. 2017. PMID: 28327804 Free article. Clinical Trial.
Beneficial and Harmful Effects of Monoclonal Antibodies for the Treatment and Prophylaxis of COVID-19: Systematic Review and Meta-Analysis.
Hernandez AV, Piscoya A, Pasupuleti V, Phan MT, Julakanti S, Khen P, Roman YM, Carranza-Tamayo CO, Escobedo AA, White CM. Hernandez AV, et al. Among authors: carranza tamayo co. Am J Med. 2022 Nov;135(11):1349-1361.e18. doi: 10.1016/j.amjmed.2022.06.019. Epub 2022 Jul 23. Am J Med. 2022. PMID: 35878688 Free PMC article.